Education
About Us
Working with TipRanks
Follow Us
Glen Taylor Insider Profile
4 Followers
Glen Taylor, Director at GlassBridge Enterprises, holds 29.04M shares in Envoy Medical (Ticker: COCH), holds 107.36K shares in GlassBridge Enterprises (Ticker: GLAE). Most recently, Glen Taylor Bought ― shares of Envoy Medical on Feb 17, 2026 for an estimated value of $7.50M.
Glen Taylor GlassBridge Enterprises (GLAE)Director
GlassBridge Enterprises (GLAE)
Director
Not Ranked
Glen Taylor has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that Glen Taylor holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Glen Taylor
Glen Taylor's Trading History
GlassBridge Enterprises
Jul 02, 2012
―
Uninformative Buy
4.50K
$3.01M
Envoy Medical
Feb 17, 2026
Ten Percent Owner
Informative Buy
7.50M
$20.30M
List of latest transactions for each holding click on a transaction to see Glen Taylor's performance on stock
You May Also Like
Glen Taylor insider profile FAQ
What is the percentage of profitable transactions made by Glen Taylor?
The percentage of profitable transactions made by Glen Taylor is ―.
What is the average return per transaction made by Glen Taylor?
The average return per transaction made by Glen Taylor is ―.
What stocks does Glen Taylor hold?
Glen Taylor holds: GLAE, COCH stocks.
What was Glen Taylor’s latest transaction?
Glen Taylor latest transaction was an Informative Buy of $7.50M.
What was Glen Taylor's most profitable transaction?
Glen Taylor’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Glen Taylor's role in GlassBridge Enterprises?
Glen Taylor's role in GlassBridge Enterprises is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.